云南白药治疗冠心病稳定型心绞痛临床观察

Clinical Observation on yunnanbaiyai capsules in Treating stable angina of Coronary

目的：对比云南白药治疗稳定型心绞痛的疗效。方法：选取2010年1月~2014年1月100例冠心病稳定型心绞痛患者为研究对象,采用随机对照法,分为观察组50例给予云南白药胶囊0.3 g,1日3次和单硝酸异山梨酯缓释胶囊50 mg,1日1次。对照组50例给予单硝酸异山梨酯缓释胶囊50 mg,1日1次。疗程均为12周。结果：观察组临床症状总有效率为92.0%,高于对照组的84.0%,且治疗后观察组心电图改善优于对照组。结论：云南白药胶囊加单硝酸异山梨酯缓释胶囊治疗稳定型心绞痛的临床疗效优于单用单硝酸异山梨酯缓释胶囊,且不良反应明显较少,患者耐受性好。

Objective：To compare the efficacy of the treatment of stable angina Yunnan Baiyao. Methods：in our hospital in January 2010 to January 2014 100 cases of stable angina patients in this study, using a randomized controlled method, divided into two groups 50 cases given Yunnan Baiyao capsules 0.3 g, three times a day and isosorbide dinitrate sustained - release capsules 50 mg, once daily. The control group of 50 patients given isosorbide dinitrate sustained - release capsules 50 mg, once daily. A course of 12 weeks of clinical symptoms. Result ： observation group total effective rate 92.0 % higher than 84.0 %, and after treatment ECG observation group than the control group. Conclusions ： Yunnan Baiyao capsules plus isosorbide dinitrate sustained - release capsules treatment the clinical efficacy of stable angina is better than alone isosorbide dlnitrate sustained release capsules, and the significantly fewer side effects, patients tolerated.